[{"from": "human", "value": "Please give me some details about this molecule. [C][N][C][C][C@][C@H1][C@H1][Ring1][=Branch1][C][C][=C][Ring1][=Branch1][C][=Branch1][#Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][O][C@H1][Ring1][=C][C][=Branch1][Branch1][=C][C][Ring1][S][O][C][=Branch1][C][=O][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a benzylic prodrug of hydrocodone. It was developed in an effort to reduce parenteral bioavailability of the active metabolite as a deterrent to abuse. Benzhydrocodone is indicated for use in the short-term management of pain. It was first approved by the FDA in February 2018 in combination with [acetaminophen] under the trade name Apadaz, marketed by KVK Tech and developed by KemPharm."}]